CanSino moved the inhaled formulation ... which is running a small trial of its mRNA-based candidate and the AstraZeneca/Oxford University vaccine to see if they can be delivered to the lungs ...

those who are not vaccinated by these pharmaceutical companies or with these vaccines are denied entry or are not accepted. So we do nothing if we vaccinate with Cansino or AstraZeneca at the border ...

AstraZeneca's share price ticked up by ... from researchers in China on another adenoviral vector-based vaccine developed by CanSino Biologics, which also generated antibody and T cell responses ...

A former AstraZeneca Pharmaceuticals LP sales worker adequately alleged she was fired after the company rejected her request ...

Chris Nemeth, 51, worked in airline logistics until he got the AstraZeneca vaccine in July 2021 and developed chronic inflammatory demyelinating polyneuropathy (CIPD) which can cause numbness ...

Both the CanSino and Bharat vaccines are based ... adenoviruses naturally infect mucosal tissue. For e.g. the AstraZeneca IN vaccine trials that are currently ongoing, the challenge would seem ...

On April 30, AstraZeneca admitted that the vaccine, sold under the name Vaxzevria, can cause fatal blood clots and low platelet counts, also known as thrombosis syndrome with thrombocytopenia ...

“At the current time, the use of the Pfizer vaccine is preferred over the AstraZeneca vaccine in adults aged less than 50 years who have not already received a first dose of AstraZeneca vaccin ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. AstraZeneca has warned it could relocate its vaccine manufacturing site on Merseyside to Philadelphia amid ...

AstraZeneca made headlines on Tuesday as it initiated the global withdrawal of its COVID-19 vaccine. This decision comes weeks after the pharmaceutical giant acknowledged the vaccine's potential ...

AstraZeneca has announced it is withdrawing its Covid-19 vaccine months after admitting in a London court that the vaccine can cause rare and dangerous side effects. AstraZeneca said that the ...

AstraZeneca Plc (NASDAQ:AZN) has reportedly warned that it might relocate its vaccine manufacturing site from Merseyside, U.K., to Philadelphia amid stalled negotiations with the U.K.’s Labour ...